172 related articles for article (PubMed ID: 21575992)
1. Barriers to achieving treatment goals: a focus on sleep disturbance and sexual dysfunction.
Morehouse R; Macqueen G; Kennedy SH
J Affect Disord; 2011 Aug; 132 Suppl 1():S14-20. PubMed ID: 21575992
[TBL] [Abstract][Full Text] [Related]
2. Major depressive disorder, antidepressants, and sexual dysfunction.
Clayton AH; Montejo AL
J Clin Psychiatry; 2006; 67 Suppl 6():33-7. PubMed ID: 16848675
[TBL] [Abstract][Full Text] [Related]
3. Limitations of current medical treatments for depression: disturbed circadian rhythms as a possible therapeutic target.
Lader M
Eur Neuropsychopharmacol; 2007 Dec; 17(12):743-55. PubMed ID: 17624740
[TBL] [Abstract][Full Text] [Related]
4. A randomized double-blind placebo-controlled trial of treatment as usual plus exogenous slow-release melatonin (6 mg) or placebo for sleep disturbance and depressed mood.
Serfaty MA; Osborne D; Buszewicz MJ; Blizard R; Raven PW
Int Clin Psychopharmacol; 2010 May; 25(3):132-42. PubMed ID: 20195158
[TBL] [Abstract][Full Text] [Related]
5. Strategies for the treatment of antidepressant-related sexual dysfunction.
Zajecka J
J Clin Psychiatry; 2001; 62 Suppl 3():35-43. PubMed ID: 11229451
[TBL] [Abstract][Full Text] [Related]
6. The ELIXIR study: evaluation of sexual dysfunction in 4557 depressed patients in France.
Bonierbale M; Lançon C; Tignol J
Curr Med Res Opin; 2003; 19(2):114-24. PubMed ID: 12740155
[TBL] [Abstract][Full Text] [Related]
7. Circadian dimension and severity of depression.
Courtet P; Olié E
Eur Neuropsychopharmacol; 2012; 22 Suppl 3():S476-81. PubMed ID: 22959112
[TBL] [Abstract][Full Text] [Related]
8. Agitated "unipolar" depression re-conceptualized as a depressive mixed state: implications for the antidepressant-suicide controversy.
Akiskal HS; Benazzi F; Perugi G; Rihmer Z
J Affect Disord; 2005 Apr; 85(3):245-58. PubMed ID: 15780694
[TBL] [Abstract][Full Text] [Related]
9. Circadian rhythms and treatment implications in depression.
Monteleone P; Martiadis V; Maj M
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug; 35(7):1569-74. PubMed ID: 20691746
[TBL] [Abstract][Full Text] [Related]
10. Enhancing pharmacologic effects in the treatment of depression in women.
Kornstein SG; McEnany G
J Clin Psychiatry; 2000; 61 Suppl 11():18-27. PubMed ID: 10926051
[TBL] [Abstract][Full Text] [Related]
11. [Residual symptoms after a treated major depressive disorder: in practice ambulatory observatory carried out of city].
Mouchabac S; Ferreri M; Cabanac F; Bitton M
Encephale; 2003; 29(5):438-44. PubMed ID: 14615693
[TBL] [Abstract][Full Text] [Related]
12. Brain circuits determine destiny in depression: a novel approach to the psychopharmacology of wakefulness, fatigue, and executive dysfunction in major depressive disorder.
Stahl SM; Zhang L; Damatarca C; Grady M
J Clin Psychiatry; 2003; 64 Suppl 14():6-17. PubMed ID: 14658930
[TBL] [Abstract][Full Text] [Related]
13. Depression, sleep, and antidepressants.
Thase ME
J Clin Psychiatry; 1998; 59 Suppl 4():55-65. PubMed ID: 9554322
[TBL] [Abstract][Full Text] [Related]
14. Female sexual dysfunction related to depression and antidepressant medications.
Clayton AH
Curr Womens Health Rep; 2002 Jun; 2(3):182-7. PubMed ID: 12099193
[TBL] [Abstract][Full Text] [Related]
15. Augmentation strategies to increase antidepressant tolerability.
Zajecka JM
J Clin Psychiatry; 2007; 68 Suppl 10():23-7. PubMed ID: 17900206
[TBL] [Abstract][Full Text] [Related]
16. Outcomes in major depressive disorder: the evolving concept of remission and its implications for treatment.
Möller HJ
World J Biol Psychiatry; 2008; 9(2):102-14. PubMed ID: 18428079
[TBL] [Abstract][Full Text] [Related]
17. The Rothschild Scale for Antidepressant Tachyphylaxis: reliability and validity.
Rothschild AJ
Compr Psychiatry; 2008; 49(5):508-13. PubMed ID: 18702938
[TBL] [Abstract][Full Text] [Related]
18. Dysfunctional beliefs and attitudes on sleep and sleep disturbances pre- and post-antidepressant treatments in patients with major depression.
Li W; Huang X; Zhang L
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Jan; 36(1):9-14. PubMed ID: 21311133
[TBL] [Abstract][Full Text] [Related]
19. [Depressive disorder, treatment and sexual dysfunction--part II].
Gałecki P; Depko A; Woźniak A; Talarowska M
Pol Merkur Lekarski; 2011 Oct; 31(184):256-9. PubMed ID: 22097187
[TBL] [Abstract][Full Text] [Related]
20. Minimizing and managing antidepressant side effects.
McElroy SL; Keck PE; Friedman LM
J Clin Psychiatry; 1995; 56 Suppl 2():49-55. PubMed ID: 7844107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
